ホーム › 転移性癌 › カリフォルニア州 › San Francisco
San Francisco、CAにおける転移性癌の臨床試験
San Franciscoとその周辺地域（約30マイル以内）の拠点で、転移性癌に関する28件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
被験者募集中第1/2相
- Avenzo Therapeutics Recruiting Site, San Francisco
Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
被験者募集中第1/2相
- University of California San Francisco, San Francisco
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
被験者募集中第3相
- UCSF at China Basin, San Francisco
- UCSF at Mount Zion, San Francisco
- UCSF at Parnassus, San Francisco
- 他1件
Intratumoral N17350 in Advanced Solid Tumors
被験者募集中第1/2相
- University of California, San Francisco, San Francisco
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
被験者募集中第1相
- UCSF Medical Center at Mount Zion, San Francisco
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
被験者募集中第3相
- UCSF Medical Center at Mission Bay, San Francisco
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
被験者募集中第3相
- Kaiser Permanente, San Francisco
- UCSF Medical Center at Mission Bay, San Francisco
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
被験者募集中第1/2相
- UCSF Medical Center at Mission Bay ( Site 0034), San Francisco
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
被験者募集中第1/2相
- University of California, San Francisco (UCSF), San Francisco
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
被験者募集中第1相
- University of California San Francisco, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
被験者募集中第1/2相
- Crinetics Study Site, San Francisco
Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases
被験者募集中第2相
- University of California, San Francisco, San Francisco
Imaging of Solid Tumors Using 18F-TRX
被験者募集中第1相
- University of California, San Francisco, San Francisco
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
被験者募集中第1相
- University of California San Francisco, San Francisco
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #5, San Francisco
Combination Therapy in Cancers With Mutations in DNA Repair Genes
被験者募集中第1相
- University of California, San Francisco, San Francisco
Imaging of Solid Tumors Using FAP-2286
被験者募集中第1相
- University of California, San Francisco, San Francisco
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
被験者募集中第1相
- University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
被験者募集中第1/2相
- University of California San Francisco (UCSF), San Francisco
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma
被験者募集中第2/3相
- University of California San Francisco - Helen Diller Family Comprehensive Cancer Center, San Francisco
Comparison of Whole Body DWI to FDG PET
被験者募集中
- University of California, San Francisco, San Francisco
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
被験者募集中第1/2相
- University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco
Venetoclax Basket Trial for High Risk Hematologic Malignancies
被験者募集中第1相
- University of California San Francisco-Benioff Children's Hospital, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
被験者募集中第1相
- University of California San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, San Francisco
A Study of NX-1607 in Adults With Advanced Malignancies
被験者募集中第1相
- University of California, San Francisco, San Francisco
他の都市における転移性癌の試験
- Houston, TX104件の研究
- New York City, NY93件の研究
- Nashville, TN70件の研究
- Boston, MA63件の研究
- Los Angeles, CA57件の研究
- St. Louis, MO54件の研究
- Arlington, VA53件の研究
- Philadelphia, PA46件の研究
- Chicago, IL45件の研究
- San Antonio, TX44件の研究
- Washington, DC43件の研究
- Dallas, TX42件の研究
San Franciscoにおける他の研究
- 前立腺がん45件の研究
- 乳がん43件の研究
- 非小細胞肺癌36件の研究
- がん（全種類）35件の研究
- 心不全29件の研究
- 肺がん22件の研究
- 悪性黒色腫22件の研究
- 膵臓がん20件の研究
- 卵巣がん19件の研究
- 大腸癌18件の研究
- 心血管疾患18件の研究
- 膠芽腫17件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。